AKT1 and heart failure: These findings demonstrate that calyculin A treatment of ILK-deficient msq embryos effectively inhibits further PKB dephosphorylation, thereby reconstituting phospho-PKB levels and rescuing cardiac contractility in msq heart failure mutants.